Loading clinical trials...
Loading clinical trials...
Observational Study in Adult Patient With Chronic Myeloid Leukemia Who Discontinue Tyrosine Kinase Inhibitors in Italy
Conditions
Locations
1
Italy
Division of Hematology-AO Mauriziano Hospital, University of Turin
Turin, Italy
Start Date
August 9, 2021
Primary Completion Date
July 8, 2022
Completion Date
February 8, 2030
Last Updated
November 18, 2021
NCT06994676
NCT06523556
NCT06236724
NCT04195633
NCT05334069
NCT05362773
Lead Sponsor
University of Turin, Italy
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions